Home › Kanser sa Ovary › Pennsylvania

Pag-aaral pangklinika para sa Kanser sa Ovary sa Pennsylvania

69 pag-aaral para sa Kanser sa Ovary ang naghahanap ng mga kalahok sa mga site sa Pennsylvania.

Mga Lungsod sa Pennsylvania

Opisyal na teksto ng pag-aaral (English)

Testing the Addition of Paclitaxel Administered Into the Abdominal Cavity Combined With Chemotherapy for Patients With Gastric Cancer Spread to the Abdominal Cavity

Thomas Jefferson University Hospital, Philadelphia
UPMC Hillman Cancer Center, Pittsburgh
UPMC-Passavant Hospital, Pittsburgh

Nagre-recruitPhase 2/3

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 5, 2026 · NCT07001748

Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial

Lehigh Valley Hospital-Cedar Crest, Allentown
UPMC Altoona, Altoona
Lehigh Valley Hospital - Muhlenberg, Bethlehem
at 18 pa

Nagre-recruitPhase 2

Lahat ng edad · Lahat ng kasarian · Na-update Okt 5, 2026 · NCT05564377

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

Abramson Cancer Center of the University of Pennsylvania, Philadelphia
University of Pittsburgh Medical Center, Pittsburgh
WellSpan York Cancer Center, York

Nagre-recruitPhase 1/2

Edad 12 pataas · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT04585750

Distance-Based Exercise to Preserve Function and Prevent Disability

UPMC Hillman Cancer Center at Butler Health System, Butler
IRMC Cancer Center, Indiana
UPMC Hillman Cancer Center - New Castle, New Castle
at 2 pa

Nagre-recruit

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT07059884

A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors

Sidney Kimmell Cancer Center - Jefferson Health, Philadelphia

Nagre-recruitPhase 1

Edad 19 pataas · Lahat ng kasarian · Na-update Okt 1, 2026 · NCT06586957

Risk Reducing Salpingectomy With Delayed Oophorectomy as an Alternative to Risk- Reducing Salpingo-oophorectomy in High Risk-Women to Assess the Safety of Prevention - US Cohort Study

University of Pennsylvania, Philadelphia

Nagre-recruit

Edad 18 pataas · Kababaihan · Na-update Set 29, 2026 · NCT05287451

A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation

Research Site, Pittsburgh

Nagre-recruitPhase 1

Edad 18 pataas · Lahat ng kasarian · Na-update Set 29, 2026 · NCT05877599

A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.

St. Lukes University Hospital /ID# 274362, Bethlehem
University of Pennsylvania - Perelman Center for Advanced Medicine /ID# 275612, Philadelphia

Nagre-recruitPhase 2

Edad 18 pataas · Kababaihan · Na-update Set 29, 2026 · NCT06890338

A Study of Azenosertib (ZN-c3) in Subjects With Platinum-Resistant High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer

Site 0232 - University of Pennsylvania, Philadelphia
Site 0178 - Thomas Jefferson University, Philadelphia

Nagre-recruitPhase 2

Edad 18 pataas · Kababaihan · Na-update Set 29, 2026 · NCT05128825

Study of AVZO-021 in Patients With Advanced Solid Tumors

Avenzo Therapeutics Recruiting Site, Philadelphia

Nagre-recruitPhase 1/2

Edad 18 pataas · Lahat ng kasarian · Na-update Set 28, 2026 · NCT05867251

DESTINY-PANTUMOUR04

Research Site, Philadelphia

Nagre-recruitObservasyonal na pag-aaral

Edad 18 hanggang 130 · Lahat ng kasarian · Na-update Set 25, 2026 · NCT07124000

A Study to Find Out How Safe REGN5668 is and How Well it Works In Adult Women When Given With Either Cemiplimab, or Cemiplimab + Fianlimab, or Ubamatamab

Perelman School of Medicine at the University of Pennsylvania, Philadelphia

Nagre-recruitPhase 1/2

Edad 18 pataas · Kababaihan · Na-update Set 24, 2026 · NCT04590326

A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer

University of Pennsylvania Hospital, Philadelphia
Jefferson Health Honickman Center, Philadelphia
Asplundh Cancer Pavilion, Willow Grove

Nagre-recruitPhase 3

Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07213804

A Study of LY4337713 in Participants With FAP-Positive Solid Tumors

University of Pennsylvania, Philadelphia
Fox Chase Cancer Center, Philadelphia

Nagre-recruitPhase 1

Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07213791

A Study to Assess Adverse Events and Change in Disease Activity of Multiple Treatment Combinations With Intravenous Mirvetuximab Soravtansine in Adult Participants With Ovarian Cancer

Penn Medicine University of Pennsylvania Health System /ID# 277963, Philadelphia
Western Pennsylvania Gynecologic Oncology /ID# 278632, Pittsburgh

Nagre-recruitPhase 2

Edad 18 pataas · Kababaihan · Na-update Set 22, 2026 · NCT07059845

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

Allegheny Health Network, Pittsburgh

Nagre-recruitPhase 1/2

Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT06128551

Prehabilitation in High-risk Oncologic Surgery

Fox Chase Cancer Center - Philadelphia, Philadelphia

Nagre-recruit

Edad 18 pataas · Lahat ng kasarian · Na-update Set 21, 2026 · NCT07638410

BI-1808 as a Single Agent and With Pembrolizumab (KEYTRUDA® ) in Treatment of Advanced Malignancies(Keynote-D20)

University of Pennsylvania, Philadelphia

Nagre-recruitPhase 1/2

Edad 18 pataas · Lahat ng kasarian · Na-update Set 18, 2026 · NCT04752826

A Clinical Trial of Sac-TMT in People With Non-HRD Positive Advanced Ovarian Cancer (MK-2870-021)

Hospital of the University of Pennsylvania ( Site 0071), Philadelphia

Nagre-recruitPhase 3

Edad 18 pataas · Kababaihan · Na-update Set 17, 2026 · NCT07318558

Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression

University of Pittsburgh Cancer Institute Cancer Services, Pittsburgh
Allegheny Health Network- West Penn Hospital, Pittsburgh
Lankenau Medical Center, Wynnewood
at 1 pa

Nagre-recruitPhase 3

Edad 18 pataas · Kababaihan · Na-update Set 15, 2026 · NCT07214779

A Study of INCB123667 in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression

Penn State College of Medicine, Hershey

Nagre-recruitPhase 2

Edad 18 hanggang 99 · Kababaihan · Na-update Set 15, 2026 · NCT07023627

ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation

University of Pennsylvania, Philadelphia
WellSpan Medical Oncology & Hematology at York Cancer Center, York

Nagre-recruitObservasyonal na pag-aaral

Edad 18 pataas · Lahat ng kasarian · Na-update Set 14, 2026 · NCT05059444

Investigation of Ubamatamab Combination Therapy in Adult Participants With Platinum-Resistant Ovarian Cancer

University of Pittsburgh Medical Center, Magee-Womens Hospital, Pittsburgh
West Penn Hospital of Allegheny Health Network, Pittsburgh

Nagre-recruitPhase 2

Edad 18 pataas · Kababaihan · Na-update Set 14, 2026 · NCT06787612

FiH Study to Investigate Safety, PK and Efficacy of the NaPi2b ADC TUB-040 in Patients With PROC or r/r Adenocarcinoma NSCLC

Allegheny Singer, Pittsburgh

Nagre-recruitPhase 1/2

Edad 18 pataas · Lahat ng kasarian · Na-update Set 14, 2026 · NCT06303505

Minimally Invasive Surgery After Neoadjuvant Chemotherapy for the Treatment of Stage IIIC-IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer, LANCE Trial

St. Luke's University Health Network, Bethlehem

Nagre-recruitPhase 3

Edad 18 pataas · Kababaihan · Na-update Set 14, 2026 · NCT04575935

A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies

Research Site, Pittsburgh

Nagre-recruitPhase 1/2

Edad 18 pataas · Lahat ng kasarian · Na-update Set 11, 2026 · NCT05123482

A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)

Allegheny Health Network West Penn Hospital ( Site 0099), Pittsburgh

Nagre-recruitPhase 3

Edad 18 pataas · Kababaihan · Na-update Set 3, 2026 · NCT06824467

FT836 With or Without Chemotherapy and/or Monoclonal Antibodies, in Participants With Advanced Solid Tumors

Thomas Jefferson University, Sidney Kimmel Cancer Center, Philadelphia

Nagre-recruitPhase 1

Edad 18 pataas · Lahat ng kasarian · Na-update Set 2, 2026 · NCT07216105

Efficacy & Safety of Olvi-Vec and Platinum-doublet + Bevacizumab Compared to Physician's Choice of Chemotherapy and Bevacizumab in Platinum-Resistant/Refractory Ovarian Cancer (PRROC) (OnPrime, GOG-3076)

AHN West Penn Hospital, Pittsburgh

Nagre-recruitPhase 3

Edad 18 pataas · Kababaihan · Na-update Ago 26, 2026 · NCT05281471

Phase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid Tumors

UPMC Hillman Cancer Center, Pittsburgh

Nagre-recruitPhase 1

Edad 15 pataas · Lahat ng kasarian · Na-update Ago 25, 2026 · NCT06276491

Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

Children's Hospital of Philadelphia, Philadelphia
Children's Hospital of Pittsburgh of UPMC, Pittsburgh

Nagre-recruitPhase 1/2

12 Months – 30 Years · Lahat ng kasarian · Na-update Ago 25, 2026 · NCT04851119

A Phase 1 Study of LNCB74 in Advanced Solid Tumors

Sidney Kimmel Comprehensive Center at Jefferson, Philadelphia
UPMC, Pittsburgh

Nagre-recruitPhase 1

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 21, 2026 · NCT06774963

A Study of MUC16-Directed Antibody Drug Conjugate HWK-016 in Participants With Advanced Solid Tumors.

SCRI - Sydney Kimmel Cancer Center - Jefferson Health, Philadelphia

Nagre-recruitPhase 1

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 18, 2026 · NCT07470853

A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors

Normunity Investigational Site, Philadelphia
Normunity Investigational Site, Philadelphia

Nagre-recruitPhase 1

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 18, 2026 · NCT07182149

The Appendix Cancer PMP Research Foundation Natural History Study/Patient Registry

ACPMP, Springfield

Nagre-recruitObservasyonal na pag-aaral

Lahat ng edad · Lahat ng kasarian · Na-update Ago 17, 2026 · NCT07769346

A Study of Azenosertib (ZN-c3) Versus Investigator's Choice Chemotherapy in Subjects With Platinum-Resistant High-Grade Serous Ovarian, Primary Peritoneal, or Fallopian Tube Cancers Positive for Cyclin E1 Protein Expression

Site 0109, Philadelphia
Site 0113, Philadelphia
Site 0114, Willow Grove

Nagre-recruitPhase 3

Edad 18 pataas · Kababaihan · Na-update Ago 12, 2026 · NCT07546500

A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer

Jefferson Abington Hospital, Abington
Christiana Care Health System-Concord Health Center, Chadds Ford
Penn State Milton S Hershey Medical Center, Hershey
at 15 pa

Nagre-recruit

Edad 35 hanggang 50 · Kababaihan · Na-update Ago 7, 2026 · NCT04251052

Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer

Lehigh Valley Hospital-Cedar Crest, Allentown
Saint Luke's Cancer Center - Allentown, Allentown
Saint Luke's University Hospital-Bethlehem Campus, Bethlehem
at 21 pa

Nagre-recruitPhase 3

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 7, 2026 · NCT06580314

Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)

USOR Alliance Cancer Specialist, Doylestown
Allegheny Health Network, Pittsburgh

Nagre-recruitPhase 1/2

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 4, 2026 · NCT05579366

A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors

University of Pennsylvania / Abramson Cancer Center, Philadelphia
Thomas Jefferson University, Sidney Kimmel Cancer Center, Clinical Research Organization, Philadelphia

Nagre-recruitPhase 1/2

Edad 18 pataas · Lahat ng kasarian · Na-update Hul 30, 2026 · NCT04657068

Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.